← Leaderboards
Kristen M Marks
Weill Medical College Of Cornell Univ
$2,115,537
Attributed
$3,521,672
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $594.7K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,521,672 · 5
By mechanism
R01$2,812,270 · 1
K23$657,450 · 1
M01$51,952 · 3
Top collaborators
- Pedro Mateu-Gelabert5 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- James Bruce Bussel$3,000,788
- Marshall J Glesby$7,651,029
Others in their field
Top investigators on “Hepatitis C”
- Constance Ann Benson · University Of California, San Diego$171,085,251
- Sharon A Nachman · Johns Hopkins University$116,441,543
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Richard Douglas Moore · Johns Hopkins University$59,121,971
- Charles R Rinaldo · University Of Pittsburgh At Pittsburgh$46,122,050
Research focus
Hepatitis CInfectionBaseSafetyDesignHiv InfectionsPreventPrevalenceUnited StatesResponsePharmaceutical PreparationsProgramsMedicalHepatitis C VirusHepatitis C TherapyAdverse EffectsDoseAdherenceDose-LimitingCountryCaringAffectDrug UsageAdverse Event
Grant awards (13)
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$534,162
R01 · FY2020 · DA
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$554,667
R01 · FY2019 · DA
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$557,431
R01 · FY2018 · DA
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$571,298
R01 · FY2017 · DA
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$594,712
R01 · FY2016 · DA
Thrombocytopenia & HIV/HCV: Risk Factors & Treatment$131,490
K23 · FY2009 · AI · contact PI
Thrombocytopenia & HIV/HCV: Risk Factors & Treatment$131,490
K23 · FY2008 · AI · contact PI
Thrombocytopenia & HIV/HCV: Risk Factors & Treatment$131,490
K23 · FY2007 · AI · contact PI
SAFETY/EFFICACY OF IV ANTI-D FOR TREATMENT OF THROMBOCYTOPENIA IN HCV$1,842
M01 · FY2007 · RR · contact PI
Thrombocytopenia & HIV/HCV: Risk Factors & Treatment$131,490
K23 · FY2006 · AI · contact PI
SAFETY/EFFICACY OF IV ANTI-D FOR TREATMENT OF THROMBOCYTOPENIA IN HCV$45,009
M01 · FY2006 · RR · contact PI
Thrombocytopenia &HIV/HCV: Risk Factors &Treatment$131,490
K23 · FY2005 · AI
SAFETY/EFFICACY OF IV ANTI-D FOR TREATMENT OF THROMBOCYTOPENIA IN HCV$5,101
M01 · FY2005 · RR